ArticleFrontiers in pediatrics2020

Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia.

Silvia Martín Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.